[1]
2011. Incretin-Based Antidiabetic Agents: A New Option for Type-2 Diabetes Mellitus. Faridpur Medical College Journal. 6, 1 (Apr. 2011), 51–54. DOI:https://doi.org/10.3329/fmcj.v6i1.7412.